Abstract:Ventricular tachycardia (VT) is the leading cause of sudden death, and the cardiac ryanodine receptor (RyR2) is emerging as an important focus in its pathogenesis. RyR2 mutations have been linked to VT and sudden death, but their precise impacts on channel function remain largely undefined and controversial. We have previously shown that several disease-linked RyR2 mutations in the C-terminal region enhance the sensitivity of the channel to activation by luminal Ca 2+ . Cells expressing these RyR2 mutants display an increased propensity for spontaneous Ca 2+ release under conditions of store Ca 2+ overload, a process we referred to as store overload–induced Ca 2+ release (SOICR). To determine whether common defects exist in disease-linked RyR2 mutations, we characterized 6 more RyR2 mutations from different regions of the channel. Stable inducible HEK293 cell lines expressing Q4201R and I4867M from the C-terminal region, S2246L and R2474S from the central region, and R176Q(T2504M) and L433P from the N-terminal region were generated. All of these cell lines display an enhanced propensity for SOICR. HL-1 cardiac cells transfected with disease-linked RyR2 mutations also exhibit increased SOICR activity. Single channel analyses reveal that disease-linked RyR2 mutations primarily increase the channel sensitivity to luminal, but not to cytosolic, Ca 2+ activation. Moreover, the Ca 2+ dependence of [ 3 H]ryanodine binding to RyR2 wild type and mutants is similar. In contrast to previous reports, we found no evidence that disease-linked RyR2 mutations alter the FKBP12.6–RyR2 interaction. Our data indicate that enhanced SOICR activity and luminal Ca 2+ activation represent common defects of RyR2 mutations associated with VT and sudden death. A mechanistic model for CPVT/ARVD2 is proposed.

An Advance in the study of ryanodine receptor mutations and malignant hyperthermia

Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Impaired Interaction Between Skeletal Ryanodine Receptors In Malignant Hyperthermia

RyR 2 Mutations Linked to Ventricular Tachycardia and Sudden Death Reduce the Threshold for Store-Overload-induced Ca 2 Release ( SOICR )

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Enhanced Store Overload–Induced Ca 2+ Release and Channel Sensitivity to Luminal Ca 2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

Progress in the study of ryanodine receptor-related muscle diseases]

Structural Insight into Ryanodine Receptor Channelopathies

Screening of the ryanodine receptor type 1 gene in a Chinese pedigree with malignant hyperthermia

Sudden Death Due to Malignant Hyperthermia with a Mutation of RYR1: Autopsy, Morphology and Genetic Analysis.

Toward a molecular understanding of the structure-function of ryanodine receptor Ca2+ release channels: perspectives from recombinant expression systems.

Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM

RyR1 mutation associated with malignant hyperthermia facilitates catecholaminergic stress‐included arrhythmia via mitochondrial injury and oxidative stress (893.8)

Research progression of RyR2-related sudden cardiac death

A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke

A Novel Saline-Soluble, Rapidly-Metabolized RyR1 Inhibitor Rescues Volatile Anesthesia-Induced Death and Environmental Heat Stroke in a Mouse Model Relevant to Malignant Hyperthermia

Bioenergetic Defects in Muscle Fibers of RYR1 Mutant Knock-in Mice Associated with Malignant Hyperthermia

Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders

Arrhythmogenic mechanism of a novel ryanodine receptor mutation underlying sudden cardiac death